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Several lines of evidence predict that specific
pathways must exist in metazoans for the escorted
movement of heme, an essential but cytotoxic
iron-containingorganic ring,within andbetweencells
and tissues, but these pathways remain obscure. In
Caenorhabditis elegans, embryonic development is
inextricably dependent on both maternally derived
heme and environmentally acquired heme. Here, we
show that the multidrug resistance protein MRP-5/
ABCC5 likely acts as a heme exporter, and targeted
depletion ofmrp-5 in the intestine causes embryonic
lethality. Transient knockdown of mrp5 in zebra-
fish leads to morphological defects and failure to
hemoglobinize red blood cells. MRP5 resides on the
plasma membrane and endosomal compartments
and regulates export of cytosolic heme. Together,
our genetic studies in worms, yeast, zebrafish, and
mammalian cells identify a conserved, physiological
role for a multidrug resistance protein in regula-
ting systemic heme homeostasis. We envision other
MRP family members may play similar unanticipated
physiological roles in animal development.
INTRODUCTION
Heme is almost ubiquitously required by living organisms as a
prosthetic group in proteins (Hamza and Dailey, 2012). Heme
is synthesized in the mitochondrial matrix but must be trafficked
to various subcellular compartments for incorporation into
hemoproteins in the cytoplasm, endoplasmic reticulum/Golgi,
lysosomes, and peroxisomes (Severance and Hamza, 2009).
However, unescorted movement of heme within a cell is inher-
ently hazardous due to the reactivity of free heme. It follows
that cells must have specific pathways for the directed move-
ment of heme within and between cells and tissues, but these
intra- and intercellular pathways remain poorly defined (Hamza
and Dailey, 2012; Severance and Hamza, 2009).
The existence of heme effluxers is all but certain, given that
free heme is toxic to cells and must be escorted to various sub-
cellular compartments. One such protein, the major facilitator
superfamily member FLVCR1, has been identified (Keel et al.,1008 Cell Metabolism 19, 1008–1019, June 3, 2014 ª2014 Elsevier In2008; Quigley et al., 2004). FLVCR1 null mice lack effective eryth-
ropoiesis and die as embryos (Keel et al., 2008). Interestingly,
mammalian Flvcr1 encodes two FLVCR isoforms: FLVCR1a
localizes to the plasma membrane, while FLVCR1b localizes to
mitochondrial membranes (Chiabrando et al., 2012). The eryth-
ropoietic defect observed in FLVCR1 mutant mouse embryos
has been attributed to the inability of FLVCR1b to export heme
from the mitochondria into the cytosol. However, exactly how
cytosolic heme reaches hemoproteins located within subcellular
organelles remains undefined (Fleming and Hamza, 2012).
We have exploitedCaenorhabditis elegans as a genetic model
organism because this roundworm is a heme auxotroph (Rao
et al., 2005). C. elegans is dependent on both maternally derived
heme for embryonic development and heme acquired from the
diet during larval growth (Rao et al., 2005). Heme is imported
into the intestine via the conserved heme permease HRG-1
and its paralog, HRG-4 (Figure 1A) (Rajagopal et al., 2008). The
intercellular heme-trafficking protein HRG-3 is secreted from
the intestine and carries heme to developing embryos (Chen
et al., 2011). HRG-2 is an extraintestinal, heme-binding mem-
brane protein that facilitates heme utilization in the worm hypo-
dermis (Chen et al., 2012). How does intestinal heme, derived
from the environment, get delivered to hemoproteins in extrain-
testinal tissues? Are these intercellular heme transport pathways
found in vertebrates? Herein, we show that a multidrug resis-
tance protein MRP-5/ABCC5 likely acts as a cellular heme
exporter and is essential for viability in C. elegans. This conclu-
sion is supported by our genetic studies in yeast, C. elegans,
zebrafish, and mammalian cell culture models, which ascribe a
physiological role for a multidrug resistance protein in regulating
systemic heme homeostasis in metazoa.RESULTS
HRG-3-Independent Pathway for Heme Transport
Our previous studies implicated HRG-3 in the directed trafficking
of heme to extraintestinal tissues, including embryos (Figure 1A).
However, hrg-3 mutant embryos are viable unless subjected to
severe maternal heme limitations in utero (Chen et al., 2011). In
fact, when worms are grown in the presence of >6 mM heme,
hrg-3 mRNA is undetectable (Chen et al., 2011). Thus, HRG-3
serves as an inducible mechanism for redirecting heme stores
only under heme-limiting conditions. These results would also
predict that, in the absence of HRG-3, an alternate pathway
exists in C. elegans.c.
Figure 1. mrp-5 Is an Essential Regulator of C. elegans Heme Homeostasis
(A) Current model of heme homeostasis pathways in C. elegans. HRG-1/4 proteins import heme into the cytosol of intestinal cells, HRG-3 is secreted from the
intestine for heme delivery to other tissues, and HRG-2 is a resident endoplasmic reticulum protein involved in heme utilization within the hypodermis.
(B) Loss ofmrp-5 results in a heme depletion signal that can be rescued by dietary heme. Left: GFP fluorescence (60–120 worms per treatment) quantified using
COPAS BioSort in IQ6011 [Phrg-1::GFP::unc-54 3
0 UTR; unc119(ed3); unc-119 rescue fragment] exposed to vector, hrg-4, or mrp-5 by feeding RNAi at varying
heme concentrations. ***p < 0.001 when compared to vector control under the same conditions (two-way ANOVA, Bonferroni post test). Right: images of IQ6011
RNAi worms supplemented with 50 mM heme. Error bars represent mean ± SEM.
(C) Loss of mrp-5, and no other mrp, results in a heme depletion signal in the heme sensor strain IQ6011. GFP fluorescence (60–120 worms per treatment)
quantified from the hrg-1 transcriptional fusion line (IQ6011) exposed to vector or RNAi against anmrp gene at 25 mM heme. GFP was quantified using COPAS
BioSort. ***p < 0.001 when compared to vector control under the same conditions (one-way ANOVA, Bonferroni post test). Error bars represent mean ± SEM.
(D) RNAi of FLVCR1 homologs in C. elegans does not activate a heme depletion signal in IQ6011. GFP fluorescence in IQ6011 was measured as in Figures 1B
and 1C. ***p < 0.001 when compared to vector control under the same conditions (one-way ANOVA, Bonferroni post test). Error bars represent mean ± SEM.
See also Figure S1.
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Metazoan Heme TransportWe postulated that membrane-bound heme transporters
would be suitable candidates for regulating systemic heme
homeostasis in the worm and consequently impact the regula-
tion of other heme-responsive genes. By individually depleting
288 heme-responsive genes, which included 41 genes encoding
transmembrane-domain containing proteins, we uncovered
mrp-5 (F14F4.5) as a potent regulator of the C. elegans trans-
genic heme sensor strain IQ6011. The IQ6011 strain expresses
GFP in the intestine from the heme-responsive hrg-1 promoter;
GFP levels in this strain are inversely correlated with heme levels
in the worm (Rajagopal et al., 2008; Sinclair and Hamza, 2010).
Depletion of mrp-5 in IQ6011 by RNAi resulted in significantly
greater GFP levels compared to control RNAi, indicating that
loss ofmrp-5 results in the animal sensing less heme (Figure 1B;
Severance et al., 2010). Importantly, this heme depletion signal
could be rescued in a concentration-dependent manner by sup-
plementation with dietary heme (Figure 1B). The increased GFP
signal observed by knockdown of the intestinal heme importerCellhrg-4 could be completely suppressed with 50 mM heme, while
the mrp-5 RNAi signal persisted even at 500 mM, indicating a
far more severe defect (Figure 1B). In addition, microarray anal-
ysis and quantitative RT-PCR studies show that mrp-5 is itself a
heme-responsive gene, because itsmRNA increased over 3-fold
under low heme conditions (Severance et al., 2010). Indeed,
in silico analysis of the putative mrp-5 promoter revealed the
presence of a canonical 23 bp heme response element, which
we have previously shown is necessary and sufficient to mediate
the heme-dependent regulation of hrg-1 in the worm intestine
(Sinclair and Hamza, 2010).
Although the C. elegans genome contains eight mrp genes
(Figure S1, red boxes, available online), mrp-5 is the only mrp
family member that significantly alters GFP expression in
IQ6011 (Figure 1C) and is the sole mrp that is transcriptionally
responsive to heme (Severance et al., 2010). Moreover, sys-
tematically depleting each of the five FLVCR worm homologs
had little or no effect on GFP levels in the heme sensor wormMetabolism 19, 1008–1019, June 3, 2014 ª2014 Elsevier Inc. 1009
Figure 2. Worm mrp-5 Is Essential for Embryonic Development and Larval Growth
(A) MRP-5membrane topology showing an N-terminal membrane-spanning domain (MSD1) consisting of six TMDs, followed by a cytosolic ATP binding cassette
(ABC) domain, a second MSD (MSD2), and a second ABC domain. Segments of MRP-5 that are deleted in the ok2067 allele are shown in red.
(B) Dead progeny of vector control or mrp-5(RNAi) worms. ***p < 0.001 when compared to vector control worms under identical conditions, n = 3 (two-way
ANOVA, Bonferroni post test). Error bars represent mean ± SEM.
(C) Top: the C. elegans mrp-5 gene contains 20 exons across 7 kb of the X chromosome. mrp-5 mutants harbor a 1.2 kb deletion (ok2067) spanning exons 14
through 17. Bottom: wild-type andmrp-5 broodmates were grown to gravid adult stage at 200 mMheme. Their F1 progeny were placed as synchronized L1 larvae
on plates seeded with OP50 bacteria with or without 200 mMadded heme. Representative images of F1 worms 4 days posthatching are shown. Scale bar, 20 mM.
(D) ZnMP staining in vector control ormrp-5(RNAi) worms. Top: worms were exposed to RNAi from L1 to L4 larval stages, pulsed with 60 mM ZnMP for 3 hr, and
imaged using confocal microscopy. Bottom: quantification of ZnMP staining (mean ± SEM of ten worms). *p < 0.05 when compared to control worms (one-way
ANOVA, Bonferroni post test).
See also Figure S2.
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Metazoan Heme Transport(Figure 1D) (Keel et al., 2008; Lipovich et al., 2002; Quigley
et al., 2004).
MRP-5 Is Essential for Embryonic and Larval
Development
In worms, mrp-5 (multidrug resistance protein 5) encodes an
ABC transporter of the MRP/ABCC family. C. elegans MRP-5
is predicted to include two membrane-spanning domains
(MSDs), each containing six transmembrane helices, and two
intracellular ATP binding cassette (ABC) domains (Figure 2A)
(Borst et al., 2000). Worms were analyzed for growth and devel-
opmental phenotypes after RNAi depletion ofmrp-5. When syn-
chronized larvae (P0) were fedmrp-5RNAi bacteria, they showed
no major developmental defects and were able to reach adult
gravid stage and lay eggs. However, 80% of the F1 eggs laid
by P0 worms failed to hatch, and the small number that did hatch
arrested as L1 larvae (Figure 2B). This striking embryonic lethal
phenotype could be rescued by supplementation of the bacterial
food with exogenous heme; 95% of F1 progeny hatched and1010 Cell Metabolism 19, 1008–1019, June 3, 2014 ª2014 Elsevier Inbecame adults in the presence of 500 mM heme. Together, these
results indicate that mrp-5 is required for embryonic develop-
ment in C. elegans.
The strain VC1599 contains a deletion in mrp-5(ok2067)
located on the X chromosome, spanning exons 14 through 17
(Figure 2C, top panel; Figure S2A), but is genetically balanced
by a marked chromosomal translocation because mrp-5
mutant worms are embryonic lethal (Edgley et al., 2006). The
mrp-5(ok2067) deletion removed 176 amino acids, including
three transmembrane helices (Figure 2A). Consequently, the
predicted topology of the mutant protein will contain only
nine transmembrane helices, resulting in a dysfunctional pro-
tein with the second ABC domain located on extracellular sur-
face (Figure S2B). Although RT-PCR and sequencing analysis
reveals the presence of mrp-5 mRNA in mutant worms (Fig-
ure S2C), depletion of mrp-5 by RNAi in the mrp-5(ok2067)
mutants does not enhance or result in additional pheno-
types, suggesting that mrp-5(ok2067) is likely a null mutation
(Figure S2D).c.
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Metazoan Heme TransportWe testedwhether supplementary heme could rescue the em-
bryonic lethality of mrp-5 mutants and found that when VC1599
worms were crossed to wild-type N2 worms to eliminate the
balancer, viable F2 homozygous mrp-5mutant worms were ob-
tained and easily propagated, but only when worms were grown
on food supplemented with >200 mM heme. When grown on
plates containing bacteria with no added heme, mrp-5(ok2067)
homozygous mutant larva arrested at midlarval stages, indi-
cating that mrp-5 is required during larval development (Fig-
ure 2C, lower panel). To determine if the rescue ofmrp-5 lethality
by dietary heme was due to the presence of redundant mecha-
nisms for heme transport, we depleted FLVCR homologs in the
mrp-5(ok2067) background. Only one, B0416.5, showed a signif-
icantly enhanced phenotype in the mrp-5 mutant worms when
depleted (Figure S2E); however, this effect could not be rescued
in a dose-dependent manner by exogenous heme and is likely
unrelated to heme export from the intestine. It is worth noting
that this experiment does not rule out the presence of other
low-affinity transporters that can compensate for the loss of
mrp-5 or the possibility that at such high dietary concentrations,
heme, which can intercalate into membrane lipids, is traversing
the membrane without the assistance of a transporter.
Because MRP-5 is a member of the ABCC/MRP transporter
family, members of which function as exporters of lipophilic
and organic compounds (Borst et al., 2007; Kos and Ford,
2009), we examined whether MRP-5 was involved in the regula-
tion of heme homeostasis in C. elegans. Worms in which mrp-5
had been depleted showed significantly greater accumulation of
zinc mesoporphyrin IX (ZnMP), a fluorescent heme analog, in
the intestine compared to control worms (Figure 2D). Notably,
VC1599 worms, which are heterozygous for mrp-5, exhibited
haploinsufficiency phenotypes, because they not only accumu-
lated ZnMP in the intestine but were also resistant to the toxic
heme analog gallium protoporphyrin IX, indicating that heme
analogs entered the intestine but were poorly accessible to
extraintestinal cells (Figures S2F and S2G).
MRP-5 Deficiency Prevents Heme Export from the
Intestine
A transcriptional reporter was generated using the putative pro-
moter region of mrp-5 (3 kb upstream of the ATG start codon)
fused to a GFP reporter. Pmrp-5::GFP was expressed at all
developmental stages, with low levels in the hypodermis and in
some neurons, and was consistently highly expressed in the
intestine and pharynx (Figure 3A), confirming published intestinal
and pharyngeal in silico gene expression analysis (Contrino et al.,
2012; McGhee et al., 2007).
To delineate the subcellular localization of MRP-5, GFP was
fused to the C terminus of MRP-5 and expressed from the intes-
tinal vha-6 promoter (Oka et al., 2001). In the polarized worm
intestinal cells, Pvha-6::MRP-5::GFP localized to basolateral
membranes and to intracellular compartments, reminiscent of
basolateral sorting vesicles in C. elegans (Chen et al., 2010) (Fig-
ure 3B; Figures S3A and S3B). Similar localization was observed
for MRP-5::GFP expressed from the endogenous mrp-5
promoter (data not shown). We next determined if the trans-
gene was capable of rescuing the embryonic lethal phenotype
induced by mrp-5 deficiency. RNAi directed against the 30 UTR
of mrp-5 depleted endogenous mrp-5, whereas the MRP-Cell5::GFP transgene, which is expressed with the generic unc-54
30 UTR, was left intact, as confirmed visually by GFP fluores-
cence (data not shown). RNAi against themrp-5 30 UTR resulted
in a significant reduction in embryonic lethality in MRP-5::GFP
transgenic worms, indicating that MRP-5::GFP is a functional
protein (Figure 3C).
Because MRP-5 is expressed in multiple tissues, it is conceiv-
able that mrp-5 depletion in any or all of the tissues may
contribute to the embryonic lethal phenotype of mrp-5 mutant
worms. To address the contribution of each tissue to the mrp-
5 phenotype, we utilized tissue-specific RNAi worm strains.
Worms carrying the rde-1mutation are resistant to RNAi; ectopic
expression of rde-1 from a tissue-specific promoter in the rde-1
mutant background results in RNAi only in that tissue (Qadota
et al., 2007). We depleted mrp-5 in the VP303 (rde-1 rescue
from the intestinal nhx-2 promoter), WM118 (rde-1 rescue from
the muscle myo-3 promoter), and NR222 (rde-1 rescue from
the hypodermal lin-26 promoter) transgenic worm lines. Deple-
tion ofmrp-5 in the intestine fully recapitulated the F1 embryonic
lethality of whole-animal RNAi, while depletion ofmrp-5 either in
the hypodermis ormuscle had no effect on F1 viability (Figure 3D).
The lethality caused by RNAi in the VP303 strain could be
rescued by supplementation with 500 mM heme in the diet.
Thus, the lethality of mrp-5 mutants can be attributed to the
loss of functional MRP-5 specifically in the intestine, even though
mrp-5 is expressed in extraintestinal tissues. This is further sup-
ported by the fact that the MRP-5::GFP transgene expressed
exclusively in the intestine (Pvha-6::MRP-5::GFP) is capable of
rescuing the hatching phenotype associated with depletion of
endogenous mrp-5 (Figure 3C).
We next determined whether MRP-5 deficiency phenotypes
could be overcome by constitutively expressing HRG-3, the
intercellular heme delivery protein, from the intestine. Ectopic
expression of hrg-3 from the intestinal vha-6 promoter was un-
able to rescue the embryonic lethality ofmrp-5 RNAi (Figure 3E).
This was not due to impaired secretion of HRG-3 from the
intestine, because HRG-3::mCherry still accumulated in the ex-
traintestinal coelomocytes when mrp-5 was depleted by RNAi
(Figure S3C).
To evaluate the heme status in an extraintestinal tissue when
mrp-5 is depleted, we utilized Phrg-2::HRG-2::YFP transgenic
worms. The hrg-2 promoter is active only in the hypodermis,
and Phrg-2::HRG-2::YFP is induced in the hypodermis when
heme levels are limiting in that tissue (Chen et al., 2012). Deple-
tion ofmrp-5 resulted in a striking increase inHRG-2::YFP levels,
and its expression was not fully suppressed until wormswere fed
500 mMheme (Figure 3F). By contrast, worms in which hrg-4, the
intestinal heme importer, was depleted did not upregulate Phrg-
2::HRG-2::YFP, indicating that loss of this particular transporter
does not result in limiting heme levels in the hypodermis. Taken
together, these results provide strong evidence that MRP-5 is
the major intestinal heme exporter.
Mrp5 Is Essential for Erythropoiesis in Zebrafish
Vertebrate ABCC5/MRP5 is 38% identical to worm MRP-5
with similar overall membrane topology. Within the ABCC/MRP
family, the lack of an additional amino-terminal MSD (called
MSD0) places ABCC5/MRP5 in a distinct group containing the
ABCC4/MRP4, ABCC7 (CFTR), and ABCC12/MRP9 proteinsMetabolism 19, 1008–1019, June 3, 2014 ª2014 Elsevier Inc. 1011
Figure 3. Worm mrp-5 Encodes a Putative Intestinal Heme Exporter
(A) GFP expression in IQ5051 [Pmrp-5::GFP::unc-54 3
0UTR; unc-119(ed3); unc-119 rescue fragment] as determined using confocal microscopy. mrp-5 is
expressed in the hypodermis and some neurons and at higher levels in the pharynx and intestine. P, pharynx; I, intestine; H, hypodermis; E, embryo. Scale
bars, 20 mM.
(B) Transgenic IQ5351 worms [Pvha-6::MRP-5:GFP::unc-54 3
0UTR; unc-119(ed3); unc-119 rescue fragment] expressing an mrp-5 translational reporter were
imaged by confocal microscopy. Dotted lines indicate apical membrane, dashed lines indicate basolateral membrane, and arrowheads indicate lateral mem-
branes between adjacent intestinal cells. Scale bar, 50 mM.
(C) TheMRP-5::GFP fusion gene can rescue the embryonic lethality ofmrp-5RNAi. RNAi targeting themrp-5ORF causes embryonic lethality in both wild-type N2
and transgenic worms. RNAi against themrp-5 30 UTR results in a less severe embryonic lethal phenotype in N2worms, but this lethality is significantly rescued by
expression of the MRP-5::GFP transgene from either the mrp-5 or the intestinal vha-6 promoter. ***p < 0.001 when compared to wild-type N2 worms under
identical conditions, n = 3 (two-way ANOVA, Bonferroni post test). Error bars represent mean ± SEM.
(D) Intestinal RNAi of mrp-5 recapitulates the embryonic lethality of whole animal mrp-5 RNAi. Wild-type N2 worms and the tissue-specific RNAi strains were
grown on RNAi plates with no added heme. Int, intestinal RNAi; Mus, muscle RNAi; Hyp, hypodermal RNAi; n = 2. See Results and Figure S2 for further strain
information. Error bars represent mean ± SEM.
(E) Ectopic expression of hrg-3 does not rescue the embryonic lethality of whole-animalmrp-5 RNAi. The experiment was performed as in Figure 1C using wild-
type N2 worms and worms ectopically expressing HRG-3 and GFP separated by the SL2 intercistronic sequence [hrg-3(tm2468); Pvha-6::HRG-3::ICS::GFP, unc-
119(ed3); unc-119 rescue fragment] grown on RNAi plates with no added heme. Error bars represent mean ± SEM.
(F) Loss ofmrp-5 activates an extraintestinal heme depletion signal. Left: yellow fluorescent protein fluorescence (60–100 worms per treatment) quantified using
COPAS BioSort in the hrg-2 translational fusion line IQ8122 [Phrg-2::HRG-2:YFP::hrg-2 3
0 UTR, unc-119(ed3); unc-119 rescue fragment] exposed to vector, hrg-4,
ormrp-5 RNAi at varying heme concentrations. ***p < 0.001, **p < 0.01 when compared to vector control worms (two-way ANOVA, Bonferroni post test). Right:
representative images of worms grown at 1 mM heme from the left panel. Left: error bars represent mean ± SEM.
See also Figure S3.
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Metazoan Heme Transport(Figure S1, blue box) (Toyoda et al., 2008). Although C. elegans
contains a single mrp-5, the gene has undergone a duplication
event, and two MRP5 paralogs are found in most vertebrates
(Figure 4A). Interestingly, the human genome contains three
paralogs; in addition to ABCC5/MRP5 on chromosome 3,
ABCC11/MRP8 and ABCC12/MRP9 are located in tandem on
chromosome 16 (Yabuuchi et al., 2001). Orthologs of ABCC11/
MRP8 can be found in other eutherians, including primates,1012 Cell Metabolism 19, 1008–1019, June 3, 2014 ª2014 Elsevier Indogs, and cows, but are not found in rodent genomes. In all
analyzed vertebrate species, the closest homolog of C. elegans
mrp-5 is the vertebrate ABCC5/MRP5.
Previous studies with HRG-1 have shown that even though
zebrafish and worm HRG-1 proteins are only 20% identical,
they are functional orthologs (Rajagopal et al., 2008). Because
zebrafish embryos provide a vertebrate animal model to interro-
gate hematological changes as a function of aberrant hemec.
Figure 4. mrp5 Is Required for Zebrafish Erythropoiesis
(A) Phylogenetic analysis of MRP5/ABCC5 clade inC. elegans (orange), zebrafish (red), mice (green), and humans (blue). Sequences were aligned using ClustalW,
and a phylogenetic tree was generated using the Neighbor-Joiningmethod inMEGA5. The tree is drawn to scale, with branch lengths in the same units as those of
the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances are in the units of the number of amino acid substitutions per site.
(B) Lateral view of zebrafish mrp5 expression by whole-mount in situ hybridization using antisense probe, 4 days postfertilization. Anterior is to the left. Sense
probe image is shown to indicate background staining. B, brain, N, neural tube.
(C) Knockdown of zebrafish mrp5 using morpholinos (MOmrp5) results in severe anemia, as indicated by reduced staining of o-dianisidine-positive red cells, as
indicated by black arrowheads.
(D) Knockdown of zebrafishmrp-5 using MOmrp5 results in reduced red cell formation. Transgenic embryos expressing GFP from the globin locus control region
(LCR-GFP) were injected with control MO or MOmrp5. Left: on day 2 postfertilization, percent GFP-positive RBCs were analyzed by FACS. x and y axes measure
GFP and forward scatter, respectively; boxed area indicates gate for RBCs. Right: quantification of morphants shown at left; error bars represent mean ± SEM.
For MOmrp5 injection, n = 4. **p < 0.01 for MOmrp5morphants compared to control morphants under identical conditions (one-way ANOVA, Bonferroni post test).
(E) Lateral view of zebrafish gata1 expression in wild-type, control MO, andMOmrp5morphants by whole-mount in situ hybridization using antisense probe 24 hpf.
Anterior is to the left.
(F) Quantification of anemia rescue in zebrafish coinjected withmrp5 cRNA. ***p < 0.001 for MOmrp5 morphants compared to control morphants under identical
conditions; n = 4. **p < 0.01 for mrp5 morphants coinjected with rescue cRNA when compared to mrp5 morphants with no rescue cRNA under identical con-
ditions; n = 3 (one-way ANOVA, Bonferroni post test).
See also Figure S4 and Table S1.
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Metazoan Heme Transporthomeostasis (Shafizadeh and Paw, 2004), we analyzed the
expression and function of mrp5/abcc5 in zebrafish. Whole-
mount in situ hybridization revealed that mrp5/abcc5 is widely
expressed throughout the embryo, with the greatest expression
in the developing central nervous system (Figure 4B; Figure S4).
To knock down mrp5/abcc5, we injected fish embryos with
morpholinos (MOs) specifically targeted against the ATG start
codon of mrp5/abcc5 (MOmrp5) mRNA. Embryos injected with
MOmrp5 showed severe anemia with very few o-dianisidine-
positive red blood cells (RBCs) compared to embryos injected
with control MOs (Figure 4C). MOmrp5 morphants also exhibited
developmental malformations, including body axis curvature
defects and enlarged hearts. The anemia phenotype was repro-
ducible using splice junction MO, which targeted specific exon-Cellintron junctions (data not shown), resulting in a mutant form of
Mrp5 that would be functionally equivalent to mutation at the
corresponding position in worm mrp-5 (Figure 2C; Figure S2A).
To quantify the severe anemia phenotype, we analyzed levels
of globin-expressing RBCs in the morphant fish. Transgenic
zebrafish expressing GFP from the globin locus control region
(LCR-GFP) were injected with control and mrp5 MOs, and
morphant blood was analyzed 2 days postfertilization (dpf) for
GFP expression. Fish injected with MOmrp5 showed significantly
decreasedGFP-positiveRBCscompared to controlMOfish (Fig-
ure 4D). Correspondingly, gata1, a transcription factor required
for primitive erythropoiesis (Paik and Zon, 2010) was robustly
expressed in wild-type and control MO embryos, but little or
nogata1 stainingwasobserved inMOmrp5morphants (Figure 4E).Metabolism 19, 1008–1019, June 3, 2014 ª2014 Elsevier Inc. 1013
Figure 5. Ectopic MRP5 Expression in Yeast Suggests the Protein Plays a Role in Heme Transport
(A) The hem1D yeast strain was transformed with indicated vectors, grown for 12 hr without added heme or ALA and then grown for 24 hr under the indicated
conditions. Yeast growth was assessed by measuring optical density 600 (OD600). Left: uninduced yeast which did not express the transgenes showed no
difference in growth after 24 hr in the presence of 250 mM ALA. Right: yeast expressing heme importers HRG-1 and HRG-4 grow significantly better than control
yeast. Yeast expressing MRP5 grow significantly worse. ***p < 0.001 compared to vector control after 24 hr; n = 3 (two-way ANOVA, Bonferroni post test). Error
bars represent mean ± SEM.
(B) The hem1D yeast strain was transformed, grown overnight without added heme or ALA, and spotted on plates supplemented with 0.5 mM heme. Plates were
incubated at 30C for 72 hr.
(C) Heme-dependent b-galactosidase activity. The hem1D yeast strain was transformed with pCYC1-LacZ as well as empty vector, ScPUG1, CeMRP-5, or
hMRP5 and grownwith the indicated amount of heme or ALA. Cell lysateswere then analyzed for b-galactosidase activity, normalized to vector. ***p < 0.001, **p <
0.01, *p < 0.05 when compared to yeast expressing empty vector under identical conditions; n = 2 (one-way ANOVA, Bonferroni post test). Error bars represent
mean ± SEM.
(D) Heme-dependent ferric reductase activity. The hem1Dfre1Dfre2DPGK1-FRE1 yeast strain was transformed with indicated vectors and grown with the
indicated amount of heme or ALA. Ferric reductase activity fromwhole cells was analyzed. **p < 0.01, *p < 0.05 when compared to yeast expressing empty vector
under identical conditions; n = 2 (one-way ANOVA, Bonferroni post test). Error bars represent mean ± SEM.
(E and F) The hem1D yeast strain expressing (E) CeHRG-4-Flag or CeMRP-5-Flag or (F) CeHRG-4 hemagglutinin (HA) or hMRP5-HA was subjected to indirect
immunofluorescence microscopy using anti-Flag or anti-HA antibodies and imaged by confocal microscopy.
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Metazoan Heme TransportThe MOmrp5 anemia was indeed due to Mrp5/Abcc5 deficiency,
because coinjecting zebrafish with cRNA encoding Mrp5/
Abcc5 significantly corrected the anemia phenotype (Figure 4F;
Table S1). Taken together, these data indicate that mrp5 is
critical for zebrafish erythropoiesis and that MRP5 regulation of
systemic heme homeostasis is likely conserved from worms to
vertebrates.
MRP5 Is a Putative Heme Transporter
To determine whether MRP5 likely transports heme, we ex-
ploited previously established assays in yeast and mammalian
cells. Saccharomyces cerevisiae hem1 mutants are unable to
synthesize d-aminolevulinic acid (ALA), a precursor for heme
synthesis, and grow poorly even in the presence of exogenous1014 Cell Metabolism 19, 1008–1019, June 3, 2014 ª2014 Elsevier Inheme due to an inefficient heme uptake system (Protchenko
et al., 2006, 2008). This inadequate growth of hem1D can be
greatly improved by either expression of a heme importer in
the presence of heme or supplementation of ALA to the growth
medium (Yuan et al., 2012). When hem1D yeast express the
C. elegans heme importer HRG-4 (CeHRG-4), they show signif-
icantly improved growth in medium supplemented with 0.5 mM
heme when compared to uninduced controls (Figure 5A) (Yuan
et al., 2012). However, yeast expressing C. elegans MRP-5 or
human MRP5 showed significantly reduced growth. Indeed,
hem1D yeast expressing CeMRP-5 or hMRP5 showed a repro-
ducible growth defect in dilution spot assays on agar plates
(Figure 5B). The reduced growth of yeast expressing CeMRP-
5 or hMRP5 was not due to cell toxicity associated withc.
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Metazoan Heme Transportoverexpression of a large polytopic membrane protein, because
growth was restored when cells were cotransformed with the
heme importer CeHRG-4 (Figure 5B, bottom three rows).
To assess whether MRP5 expression could alter heme levels
in the yeast, wemeasured the activity of b-galactosidase derived
from the lacZ reporter under control of the CYC1 promoter. This
promoter is activated by Hap1, a transcription factor positively
regulated by cytosolic heme levels (Hon et al., 2003). Yeast ex-
pressing CeMRP-5 or hMRP5 showed decreased b-galactosi-
dase activity (Figure 5C), a result consistent with the poor growth
phenotype in the spot assay. This result was reproducible in
yeast grown in the presence of ALA, indicating that MRP5
can also affect availability of endogenously synthesized heme
(Figure 5C, right panels). Interestingly, yeast expressing MRP5
showed lower b-galactosidase activity than cells expressing
the yeast heme effluxer Pug1p (Protchenko et al., 2008).
To evaluate heme availability in the yeast secretory compart-
ment, we measured ferric reductase activity, because Fre1p
acquires a heme cofactor needed for enzymatic activity in the
secretory pathway (Dancis et al., 1990). While Pug1p expression
had minimal effect, yeast expressing CeMRP-5 or hMRP5
showed significantly greater ferric reductase activity in the pres-
ence of heme and ALA (Figure 5D). Although most MRP trans-
porters expressed in yeast localize to the vacuolar membranes
(Paumi et al., 2009), indirect immunofluorescence microscopy
localized CeMRP-5 and hMRP5 primarily to intracellular com-
partments that are distinct from the plasma membrane and the
vacuole (Figures 5E and 5F). These results indicate that when ex-
pressed in yeast, MRP5 proteins are likely capable of exporting
heme from the cytosol into intracellular organelles for delivery to
hemoproteins such as Fre1p.
MRP5 Alters Heme Levels in the Secretory
Compartment
In mammals, MRP5 is expressed almost ubiquitously (Borst
et al., 2007; McAleer et al., 1999; Suzuki et al., 2000), and
Mrp5 knockout mice, previously generated in the FVB genetic
background, are viable with no overt phenotypes (de Wolf
et al., 2007). To determine how loss of Mrp5 affected heme ho-
meostasis in a mammalian cell model, we generated mouse em-
bryonic fibroblasts (MEFs) from Mrp5+/+ and Mrp5/ embryos.
Probing MEF lysates with M5I-10, a monoclonal antibody
generated against the first 38 amino acids of the mouse Mrp5,
revealed a band of the expected molecular weight by immuno-
blotting (Figure 6A) (Scheffer et al., 2000). The antibody recog-
nized endogenous Mrp5 in cell lysates from Mrp5+/+ MEFs, as
well as human MRP5 ectopically expressed in Mrp5/ MEFs.
Human MRP5 colocalized with the basolateral membrane
marker Na+-taurocholate cotransporting polypeptide (NTCP)
and not with the apical membrane marker syntaxin 3 (SYN3) in
polarized MDCKII cells (Figure 6B). In Mrp5+/+ MEFs, endoge-
nous Mrp5 was found in punctuate intracellular vesicles
throughout thecytoplasm,with someproteinon thecell periphery
(Figure 6C). Confocal microscopy studies inMrp5/MEFs colo-
calizedMRP5not onlywith theplasmamembrane (WGA) but also
partially with theGolgi (galactosyltransferase) and endosomal re-
cycling organelles (Rab4, Rab5, Rab9, and Rab11) (Figure 6D).
To verify the yeast results, we transfected Mrp5+/+ and
Mrp5/ MEFs with an engineered horseradish peroxidaseCell(HRP) that was confined to the Golgi with a targeting sequence
(White et al., 2013). Because holo-HRP requires heme as a
cofactor, HRP activity reflects heme availability in the Golgi
compartment (White et al., 2013). When heme-depleted MEFs
expressing HRP were supplemented with heme in the growth
medium, robust HRP activity was detected in Mrp5+/+ cells,
but notMrp5/ cells; HRP activity was significantly suppressed
by 65% to 80% in Mrp5/ cells (Figure 6E). Together, these
results in yeast and mouse cells support a composite model in
which MRP5 is a heme exporter that transports heme from the
cytosol into the lumen of the secretory pathway (Figure 6F).
DISCUSSION
The nematode C. elegans is unable to synthesize heme and
therefore is innately dependent on a network of heme sensing,
trafficking, and transporting molecules to import environmental
heme into the intestine and then export this heme to different
tissues and subcellular compartments. In the current study, we
show that MRP-5 plays an essential role in C. elegans heme
homeostasis and that heme is potentially the physiologically
relevant substrate of MRP5 across metazoans. For almost
two decades, MRP5 has been studied as an exporter of cancer
drugs, organic anions, and nucleoside monophosphates,
although none of these studies provided direct genetic evidence
for a physiological role for MRP5 in growth and development
(Borst et al., 2007; Kool et al., 1997; Wijnholds et al., 2000).
Our conclusions about MRP-5 function are supported by the
following findings: (1) targeted mrp-5 deficiency in the intestine
causes embryonic lethality; (2) MRP-5 primarily localizes to the
basolateral plasma membrane, and MRP-5 deficiency results
in ZnMP accumulation in the worm intestine; (3) mrp-5 is ex-
pressed during all developmental stages and over a wide range
of heme concentrations; and (4) functional heme transport as-
says in yeast suggest that MRP-5 has the capability to export
heme. Altogether, these results suggest that MRP-5 is an impor-
tant membrane-bound heme exporter in C. elegans.
An unanticipated consequence of MRP-5 deficiency in worms
is the apparent disconnect between heme levels in the intes-
tine and levels in extraintestinal tissues. In the absence of an
intestinal heme exporter, it would be expected that heme will
accumulate in the intestine and extraintestinal tissues will be
heme-deprived, as seen in the HRG-2::YFP reporter strain.
However, depletion of mrp-5 also results in robust expression
of the Phrg-1::GFP intestinal heme reporter, and this occurs
when heme is accumulating within the intestine, a condition
when such transporters are not normally expressed. If the hrg-
1 promoter was solely regulated by intestinal heme levels, then
we would expect intestinal GFP to be suppressed. It could be
that mrp-5 depletion causes compartmentalization of accumu-
lated heme in the intestine such that this heme can no longer
be detected by the hrg-1 promoter. However, another plausible
interpretation of this paradox is that intestinal heme levels are
integratedwith and regulated by ‘‘heme signals’’ from extraintes-
tinal tissues. That low extraintestinal heme levels activate a
depletion signal within a heme-loaded intestine implies the exis-
tence of a network for communicating heme status between
extraintestinal tissues and their sole source of heme, the intes-
tine. We envisage that cellular heme levels in C. elegans, andMetabolism 19, 1008–1019, June 3, 2014 ª2014 Elsevier Inc. 1015
Figure 6. MRP5 Localizes to the Secretory Pathway and Alters Heme Levels in This Compartment
(A) Immunoblot analysis of Mrp5 expression in MEFs generated from Mrp5+/+ and Mrp5/ FVB mice. Cell lysates were resolved on SDS/PAGE and blotted to
nitrocellulose membranes for probing with a monoclonal anti-MRP5 antibody.
(B) MDCKII cells stably expressing human MRP5 were transfected with the basolateral marker NTCP-GFP or the apical marker Syntaxin3-GFP and grown to
confluency on transwell filters. Polarization of the monolayer was determined after measuring a transient spike in trans-epithelial electrical resistance, which
remained above baseline level. Cells were fixed and probed with monoclonal anti-MRP5, followed by Alexa 568-conjugated secondary antibody, and imaged
using confocal microscopy. A single confocal section (xy) is depicted along with composite stacks in side views (yz, xz).
(C) Immunohistochemistry of endogenous Mrp5 in Mrp5+/+ and Mrp5/ mouse MEFs. Mrp5 staining was performed as in Figure 6B, using an Alexa 488-
conjugated secondary antibody. Scale bar, 20 mM.
(D) Immunolocalization of humanMRP5 overexpressed inMEFs by confocal microscopy. WGA is used as a plasmamembrane (PM) marker, RFP-GalT is a trans-
Golgi (TGN) marker, Rab4YFP marks early endosomes (EE) and the endocytic recycling compartment (ERC), Rab5YFP marks EEs, Rab9YFP marks late
endosomes (LE), and the TGN, Rab11YFP marks the ERC and TGN. Scale bar, 20 mM.
(E) Heme-dependent horseradish peroxidase (HRP) activity inMrp5+/+ orMrp5/MEFs. Cells were transfectedwithGolgi-HRP and then grown for 24 hr in heme-
depletedmedia plus succinyl acetone (HD+SA) for complete heme depletion. Indicated amounts of hemewere added back and cells were incubated for a further
24 hr. Cell lysates were harvested and analyzed for peroxidase activity, which was normalized to peroxidase activity from samples not expressing Golgi-HRP and
then to the protein concentration of each sample. ***p < 0.001 for knockout MEFs when compared to wild-type MEFs under identical conditions; n = 3 (two-way
ANOVA, Bonferroni post test). Error bars represent mean ± SEM.
(F) Proposed model for heme transport by MRP5. In this composite model, based on results from genetic, biochemical, and localization studies in worm and
mammalian systems, MRP5 can localize to the plasmamembrane for heme export as well as to the secretory pathway for heme delivery to luminal hemoproteins.
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content (cell autonomous) but also by distally located pro-
teins that signal systemic heme requirements to an intertissue
heme trafficking network (cell nonautonomous). This prediction
is further supported by our findings that depletion of either
a heme exporter (mrp-5) or a heme importer (hrg-1) produces
similar, overlapping phenotypes in worms and zebrafish, i.e.,
that mobilization of heme in and out of tissues is as important
as endogenous heme synthesis (Rajagopal et al., 2008; White
et al., 2013; Yuan et al., 2012). Although both heme importers
and exporters are obviously essential for survival of a heme1016 Cell Metabolism 19, 1008–1019, June 3, 2014 ª2014 Elsevier Inauxotroph, these proteins also play an important role in verte-
brates as demonstrated by developmental and blood defects
in zebrafish.
Given the severe phenotypes associated with mrp-5 defi-
ciency in worms and zebrafish, why doMrp5 null mice not exhibit
any overt hematological phenotypes? Clearly, worm and human
MRP5 have similar phenotypes in yeast. One plausible expla-
nation could be that in mammals, FLVCR1 isoforms play a
prominent role in heme export, while MRP5 performs a more
specialized role (Chiabrando et al., 2012; Fleming and Hamza,
2012; Keel et al., 2008). It is notable that worms in which eachc.
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dependent phenotypes, signifying that, at least in lower meta-
zoans, MRP5 plays a definitive and essential role in heme
homeostasis. A second explanation is the influence of the FVB
genetic background of the Mrp5 mutant mouse (de Wolf et al.,
2007). Inherently, the FVB strain has high liver and spleen iron
content and is therefore ill-suited for studies of systemic iron ho-
meostasis. This is in contrast to the C57BL/6 strain, which has a
much lower liver and spleen iron content and, therefore, presents
a mouse model that is more sensitive to perturbation in iron
metabolism (Wang et al., 2007). For example, mutations in the
iron transporter DMT1 are viable in certain mouse strains but
become lethal when backcrossed into the C57BL/6 background
(M. Fleming, personal communication). Lastly, in vivo compen-
satory pathways may exist to overcome heme or iron meta-
bolism defects inMrp5/ mice. It is noteworthy that in humans
and other placental mammals, MRP5/ABCC5 has two recently
described paralogs, ABCC11 and ABCC12; mice and zebrafish
genomes contain only ABCC12 (Kruh et al., 2007; Tammur et al.,
2001; Yabuuchi et al., 2001). Although it has been reported
that MRP9/ABCC12 also localizes to the secretory pathway in
unpolarized mammalian cells (Ono et al., 2007), the functions
of ABCC11 and ABCC12 are largely unknown.
In worms, yeast, andmammalian cells, MRP5 localizes to both
the plasma membrane and intracellular vesicles. The cell-sur-
face localization of MRP5 could be reconciled by the well-stud-
ied function of ABCC transporters to efflux substrates into the
extracellular milieu, consistent with the expected role of export-
ing heme from the C. elegans intestine into the worm’s circula-
tory system. However, MRP5 is also found in the secretory
pathway as part of the endocytic recycling compartment. While
we do not show that MRP5 has heme export activity by direct
biochemical assays or that it can deliver heme to an endo-
genously expressed mammalian hemoprotein, our genetic and
cell biological results in yeast and MEFs support a model in
which heme transported into the secretory pathway by MRP5
is incorporated into luminal hemoproteins (Figure 6F). The endo-
somal trafficking of MRP5 could be mediated by an acidic-dileu-
cine-based sorting signal located in the cytoplasmic carboxy
termini of vertebrate MRP5 proteins (Bonifacino and Traub,
2003). It is noteworthy that ATP7A, a copper-transporting
P-type ATPase, pumps copper into the secretory compartment
for metallation of essential cuproproteins in the Golgi as well
as exports copper across the plasma membrane to regulate
body copper stores (Lutsenko and Petris, 2003). Conceivably,
MRP5may perform a similar dual function as a heme transporter.
EXPERIMENTAL PROCEDURES
Strains and Vertebrate Experiments
All vertebrate animal experiments were approved by the University of Mary-
land Institutional Animal Care and Use Committee. Wild-type zebrafish were
obtained from the Zebrafish International Resource Center and were staged,
raised, and maintained as described previously (Kimmel et al., 1995; Wester-
field, 2000). Some worm strains were obtained from the Caenorhabditis
Genetics Center, which is funded by National Institutes of Health Office of
Research Infrastructure Programs (P40 OD010440). All worm strains used
in this study are listed in Table S2. Worms were maintained either in liquid
mCeHR2 or on Nematode Growth Medium agar plates (Nass and Hamza,
2007). C. elegans transcriptional and translational reporters were generated
using Multisite Gateway recombination (Invitrogen) and introduced intoCellunc-119 worms using the PDS-1000 particle delivery system (Bio-Rad)
(Chen et al., 2011).
Worm Sorting and Imaging
Worms were grown from the L1 larval stage to the early adult stage on RNAi
plates. Worms for each condition were analyzed for time of flight (length)
and extinction (optical density) using a COPAS BioSort (Union Biometrica)
with gating parameters for mixed worm populations as in Chen et al. (2011).
GFP, yellow fluorescent protein, and ZnMP fluorescence in worms was
imaged using a DMIRE2 epifluorescence microscope (Leica) connected to a
Retiga 1300 cooled mono 12-bit camera or using a laser scanning confocal
microscope (LSM710) (Zeiss).
Zebrafish Experiments
Zebrafish knockdowns were performed using 1.4 nl per embryo of 0.5 M
MO injected into one-cell-stage embryos (Rajagopal et al., 2008). Embryos
were analyzed at 24–72 hr postfertilizion (hpf) by o-dianisidine staining for
hemoglobinization, for LCR-GFP expression, and for gata1 expression using
standard procedures (Ganis et al., 2012). Pools of50 embryoswere analyzed
by fluorescence-activated cell sorting (FACS) from wild-type, control MO, and
mrp5 MO-injected LCR-GFP fish. Whole-mount in situ hybridization was per-
formed on wild-type embryos with anmrp5 cDNA probe at one cell to 5 dpf, as
well as on wild-type, control, and mrp5 morphants with a gata1 cDNA probe
using standard procedures at 24 hpf (Hauptmann, 1999). Rescue injections
were performed using 175 pg of rescue construct.
Yeast Assays
S. cerevisiae strainsweregrownandassaysperformedasdescribedpreviously
(Yuan et al., 2012). Plasmids encoding potential heme transporters were trans-
formed into yeast using the lithium method. Before each assay, yeast were
heme-starved by growth in 2% w/v raffinose SC (-Ura) liquid medium. Please
see Supplemental Experimental Procedures for information regarding the
growth assays, the b-galactosidase assay, and the ferric reductase assay.
Mammalian Cell Culture and HRP Assays
Mammalian cell lines were cultured in growth medium consisting of Dul-
becco’s modified Eagle’s medium (DMEM), 10% fetal bovine serum (FBS),
and 1% PSG (100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-gluta-
mine). Golgi-targeted HRPwas transfected intoMEFs using the Lipofectamine
transfection reagent (Invitrogen). Following overnight transfection, MEFs were
incubated in heme-depleted media (DMEM with 10% heme-depleted FBS
and 0.5 mM succinylacetone) for 24 hr. Following heme depletion, cells were
switched to heme-depleted media with added heme for 24 hr and harvested
for peroxidase activity (White et al., 2013).
Bioinformatics and Statistics
ClustalW and MEGA5 were used to generate a phylogenetic tree for the
full-length sequences of all human, mouse, zebrafish, and C. elegans MRP/
ABCC proteins (Larkin et al., 2007; Tamura et al., 2011). Membrane protein to-
pologies were generated using TMHMMand drawn using TOPO2 (http://www.
sacs.ucsf.edu/TOPO2/; Krogh et al., 2001). All data are presented as mean ±
SEM. Statistical significance was determined using one-way or two-way
ANOVAwith Bonferroni post tests in GraphPad Prism, version 5.00 (GraphPad
Software, Inc).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2014.03.030.
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